DEVICE AND METHOD FOR MODULATING RENAL FUNCTION

• US 20130237954A1
• Filed: 04/22/2013
• Published: 09/12/2013
• Est. Priority Date: 12/07/2006
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Shuros, Allan C., Brooke, M. Jason, Poonawala, Tasneem
• Granted Patent: US 9,616,228 B2
• Time in Patent Office: Days
• US Class Current: 604/500
• CPC Class Codes: A61M 25/00 Catheters; Hollow probes dilators A61M29/00; peritoneal catheters A61M1/285; tracheal tubes A61M16/04; for drainage A61M27/00; for uterus, vagina or rectum A61M31/00 ; for measuring or testing A61B; materials for catheters A61L29/00
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/3606 adapted for a particular treatment
• CPC Class Codes: A61N 1/3614 based on impedance measurement

Abstract

Renal function may be modulated by an implantable device having one or more leads or catheters disposed near the kidney via the lymphatic system. In one embodiment, lymphatic drainage from the kidney is modulated to increase or decrease tubular reabsorption of salt and water. The renal function modulation therapy may be delivered in an open-loop or closed-loop fashion, with the latter dependent upon a physiological variable such as blood pressure or cardiac output.

Claims

1. A device, comprising:

a controller;

pulse generation circuitry operable by the controller;

one or more stimulation electrodes connected to the pulse generation circuitry adapted for endolymphatic disposition near the renal nerve; and

wherein the controller is programmed to operate the pulse generation circuitry to deliver neural stimulation to the renal nerve.

2. The device of claim 1 wherein the neural stimulation inhibits sympathetic activation of the kidney.

3. The device of claim 1 wherein the neural stimulation enhances sympathetic activation of the kidney.

4. The device of claim 1 wherein the pulse generation circuitry delivers hyperpolarizing stimulation to the renal nerve.

5. The device of claim 1 wherein the pulse generation circuitry delivers depolarizing stimulation to the renal nerve.

6. The device of claim 1 further comprising:

a drug injector operable by the controller; and

, a drug delivery catheter connected to the drug injector and adapted for endolymphatic disposition near a kidney.

7. The device of claim 1 further comprising:

a blood pressure sensor for providing a blood pressure measurement to the controller; and

,

wherein the controller is programmed to operate the pulse generation circuitry in closed-loop fashion in dependence upon the blood pressure measurement.

8. The device of claim 1 further comprising:

a cardiac output sensor for providing a cardiac output measurement to the controller; and

,

wherein the controller is programmed to operate the pulse generation circuitry in closed-loop fashion in dependence upon the cardiac output measurement.

9. The device of claim 1 further comprising:

an exertion level sensor;

a cardiac output sensor; and

,

wherein the controller is programmed to compute a cardiac function index that reflects the adequacy of cardiac output for a particular exertion level and further programmed to operate the pulse generation circuitry in closed-loop fashion in dependence upon the computed cardiac function index.

10. The device of claim 1 further comprising:

a transthoracic impedance sensor for detecting pulmonary edema; and

wherein the controller is programmed to operate the pulse generation circuitry in closed-loop fashion in dependence upon the detection of pulmonary edema.

11. A method, comprising:

introducing one or more stimulation electrodes into a renal lymphatic vessel near the renal nerve;

connecting the stimulation electrodes to pulse generation circuitry operated by a controller;

programming the controller to operate the pulse generation circuitry to deliver neural stimulation to the renal nerve.

12. The method of claim 11 wherein the neural stimulation inhibits sympathetic activation of the kidney.

13. The method of claim 11 wherein the neural stimulation enhances sympathetic activation of the kidney.

14. The method of claim 11 wherein the pulse generation circuitry delivers hyperpolarizing stimulation to the renal nerve.

15. The method of claim 11 wherein the pulse generation circuitry delivers depolarizing stimulation to the renal nerve.

16. The method of claim 11 further comprising:

endolymphatically disposing a drug delivery catheter connected to a drug injector near a kidney; and

operating the drug injector with the controller.

17. The method of claim 11 further comprising:

providing a blood pressure measurement to the controller; and

,

programming the controller to operate the pulse generation circuitry in closed-loop fashion in dependence upon the blood pressure measurement.

18. The method of claim 11 further comprising:

providing a cardiac output measurement to the controller; and

,

programming the controller to operate the pulse generation circuitry in closed-loop fashion in dependence upon the cardiac output measurement.

19. The method of claim 11 further comprising:

an exertion level sensor;

a cardiac output sensor; and

,

programming the controller to compute a cardiac function index that reflects the adequacy of cardiac output for a particular exertion level and further to operate the pulse generation circuitry in closed-loop fashion in dependence upon the computed cardiac function index.

20. The method of claim 11 further comprising:

detecting pulmonary edema; and

programming the controller to operate the pulse generation circuitry in closed-loop fashion in dependence upon the detection of pulmonary edema.